Clinical Trials
14 trialsNCT05341284 2025-08-14
HPV-RWS
Peking University
Withdrawn
NCT06362421 2025-07-31
Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
Wake Forest University Health Sciences
Withdrawn
NCT04142398 2025-06-06
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
AIDS Malignancy Consortium
Withdrawn
NCT00733122 2025-03-03
Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)
Merck Sharp & Dohme LLC
Phase 3 Withdrawn
NCT00501189 2024-06-11
Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities
Eisenhower Army Medical Center
Withdrawn
NCT05316064 2024-05-10
Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic
Universiti Sains Malaysia
Phase 2/3 Withdrawn
NCT04430907 2021-07-02
HPV Vaccine in Postpartum Women
Milton S. Hershey Medical Center
Withdrawn
NCT04044950 2020-09-22
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT03887793 2020-02-26
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery Systems
University of North Carolina, Chapel Hill
Phase NA Withdrawn
NCT02382419 2019-08-01
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
Rutgers, The State University of New Jersey
Phase 2 Withdrawn
NCT02082639 2015-07-20
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years
GlaxoSmithKline
Phase 3 Withdrawn
NCT02100618 2015-07-20
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study
GlaxoSmithKline
Phase 3 Withdrawn
NCT00736216 2015-03-19
Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults
Case Comprehensive Cancer Center
Withdrawn
NCT01551537 2013-09-09
Post-marketing Surveillance of GSK Biologicals' Cervarixâ„¢ When Administered to Healthy Females in Sri Lanka
GlaxoSmithKline
Withdrawn